IPO Calendar Features Year’s First Venture-Backed Tech Company

Just two of four scheduled  initial public offerings (IPOs) went off as planned last week and four more plus one re-try are on the calendar for the coming week. Of the coming week’s new offerings only one is a healthcare company.

Intellia Therapeutics Inc. (NASDAQ: NTLA) priced at the high end of its expected IPO range, $18, and upsized its offer from 5 to 6 million shares, raising $108 million. The gene-editing company began trading Friday and closed up 23%. Insiders bought at least 42% of the deal.

Spring Bank Pharmaceuticals (NASDAQ: SBPH) priced at $12, the low end of its prospective range, and sold 920,000 shares to raise $11 million. Insiders took at least 55% of the IPO shares.

Through the week ending April 22nd, IPO ETF manager Renaissance Capital reported that 187 IPOs have priced in the U.S. so far this year, down about 68% from a year ago. Total proceeds raised through last week equaled $3.1 billion, down nearly 70% compared with the same period in 2015. Of the 18 IPOs that have gone off this year, 12 have come from the healthcare sector. Last year’s IPO total came in at $30 billion on 170 offerings. Renaissance Capital does not include “best efforts” or blank-check companies in its totals.

The two IPOs that did not make the grade last week are now listed as day to day.

Cancer Prevention Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company developing and commercializing therapeutic agents to treat and prevent certain pre-cancerous conditions, orphan diseases, and gastrointestinal conditions. The company is offering 1.9 million shares in an expected price range of $12 to $14 to raise $25 million at an implied market cap of $96.5 million. Sole bookrunner for the offering is Aegis Capital Corp. Shares are listed as day to day and are expected to trade on the New York Stock Exchange under the ticker symbol CPP.

Oncobiologics Inc. is a clinical-stage biopharmaceutical firm identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. The company plans to offer 5 million shares in an expected price range of $11 to $13 to raise $60 million at an implied market cap of $241.8 million. Joint bookrunners for the offering are Jefferies and Barclays. Co-manager is Cantor Fitzgerald. Shares are listed as day to day and are expected to trade on the Nasdaq under the ticker symbol ONS.

The first of the coming week’s new hopefuls is Turning Point Brands Inc. sells a variety of other tobacco products (not including pre-made cigarettes) such as moist snuff, loose leaf chewing tobacco, and cigarette rolling papers. The company plans to offer 5.4 million shares in an expected price range of $13 to $15 to raise about $76 million at an implied market cap of around $243 million. Joint bookrunners for the offering are Cowen & Co. and FBR Capital Markets. Shares are expected to price Tuesday and begin trading Wednesday on the New York Stock Exchange under the ticker symbol TPB.

SiteOne Landscape Supply Inc. is the largest and only national wholesale distributor of landscape supplies in the U.S. The company plans to offer 10 million shares in an IPO price range of $20 to $22 raising $210 million at an implied market cap of around $830 million. Joint bookrunners for the offering include Deutsche Bank, Goldman Sachs, UBS Investment Bank, Barclays, Baird, RBC Capital Markets, and William Blair. Co-managers include SunTrust Robinson Humphrey, ING, HSBC Corp., Natixis, SMBC Nikko, and Academy Securities. Shares are scheduled to price Wednesday and begin trading Thursday on the New York Stock Exchange under the ticker symbol SITE.

Viamet Pharmaceuticals Holdings LLC is a biopharmaceutical company developing metal-binding therapeutics for treating fungal diseases. The company plans to offer 5.7 million shares in an expected price range of $14 to $16, raising about $86 million at an implied market cap of around $389 million. Joint bookrunners for the offering are Morgan Stanley and Goldman Sachs. Co-managers are Guggenheim Securities and Needham & Co. Shares are set to price Wednesday and begin trading Thursday on the Nasdaq under the ticker symbol VMET.

Acacia Communications Inc. makes high-speed optical interconnection products for network applications. The company plans to offer $4.5 million shares in an IPO price range of $21 to $23, raising $99 million at an implied market cap of $1.54 billion. Joint bookrunners for the offering are Goldman Sachs, BofA/Merrill Lynch, and Deutsche Bank. Co-managers are Needham & Co., Cowen & Co., and Northland Securities.